+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Investigation Report on China's Mecobalamin Market, 2018-2022

  • ID: 4720149
  • Report
  • December 2018
  • Region: China
  • 30 pages
  • China Research & Intelligence
1 of 4

FEATURED COMPANIES

  • Eisai China Inc.
  • Eisai Co., Ltd.
  • MORE

Peripheral neuropathy is a syndrome caused by many factors.

Mecobalamin is a peripheral nerve repair agent. Mecobalamin tablets are used to treat peripheral neuropathy and diseases caused by vitamin B12 deficiency by repairing damaged nerves, relieving pain and numbness, and alleviating sensory disturbances and movement abnormalities. Mecobalamin injection can be used to treat megaloblastic anemia.

Developed by Eisai Co., Ltd., Mecobalamin (trade name: Methycobal) was launched in Japan in the mid-1980s and introduced to China in 1996. Since 2003, several Chinese pharmaceutical companies have launched generic Mecobalamin products. Mecobalamin has been developing rapidly since it entered China, with its annual sales value increasing from less than CNY 200 million in 2005 to about CNY 609 million in 2017. There is a huge demand for Mecobalamin in China. China’s Mecobalamin market is dominated by Eisai China Inc., Eisai Co., Ltd., Jiangsu Sihuan Biopharmaceutical Co., Ltd., Nanjing Hailing Pharmaceutical Co., Ltd., North China Pharmaceutical Company Ltd., etc. In 2017, the market share by sales value of Eisai Co., Ltd. and its subsidiary Eisai China Inc. totalled about 70%.

It is expected that as lifestyle changes and the population ages, and the incidences of peripheral neuropathy and megaloblastic anemia gradually increases, Mecobalamin will still have some growth potential in China.

Topics Covered:

  • Indications for Mecobalamin
  • Sales of Mecobalamin in China
  • Competition on China's Mecobalamin market
  • Major Mecobalamin manufacturers in China
  • Prices of Mecobalamin in China from 2017 to 2018
  • Major factors influencing the development of China's Mecobalamin market
  • Prospect of China's Mecobalamin market from 2018 to 2022
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Eisai China Inc.
  • Eisai Co., Ltd.
  • MORE

1 Relevant Concepts of Mecobalamin
1.1 Indications for Mecobalamin
1.2 Development of Mecobalamin in China
1.3 Governmental Approval of Mecobalamin in China

2 Sales of Mecobalamin in China, 2013-2017
2.1 Sales Value of Mecobalamin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Mecobalamin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Mecobalamin by Dosage Form in China, 2013-2017
2.3.1 Sales of Mecobalamin Tablets in China
2.3.2 Sales of Mecobalamin Capsules in China
2.3.3 Sales of Mecobalamin Injections in China

3 Analysis of Major Mecobalamin Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Mecobalamin Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Eisai China Inc.
3.2.1 Enterprise Profiles
3.2.2 Sales of Eisai China Inc.'s Mecobalamin
3.3 Eisai Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Eisai Co., Ltd.'s Mecobalamin in China
3.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin in China
3.5 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
3.6 North China Pharmaceutical Company Ltd.

4 Prices of Mecobalamin in China, 2017-2018
4.1 Eisai China Inc. (Methycobal)
4.2 Eisai Co., Ltd. (Methycobal)
4.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. (Zhuohe)
4.4 Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd. (Qixin)
4.5 North China Pharmaceutical Company Ltd. (Yishenbao)

5 Prospect of China's Mecobalamin Market, 2018-2022
5.1 Major Factors Influencing Development of China's Mecobalamin Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

Selected Charts
Chart Governmental Approval of Mecobalamin in China
Chart Sales Value of Mecobalamin in China, 2013-2017
Chart Sales Value of Mecobalamin in Parts of China, 2013-2017
Chart Sales Volume of Mecobalamin in China, 2013-2017
Chart Sales Volume of Mecobalamin in Parts of China, 2013-2017
Chart Sales Value of Mecobalamin Tablets in China, 2013-2017
Chart Sales Volume of Mecobalamin Tablets in China, 2013-2017
Chart Sales Value of Mecobalamin Capsules in China, 2013-2017
Chart Sales Value of Mecobalamin Injections in China, 2013-2017
Chart Market Share of Top 5 Mecobalamin Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Mecobalamin Manufacturers by Sales Volume in China, 2013-2017
Chart Profile of Eisai China Inc.
Chart Sales Value of Eisai China Inc.'s Mecobalamin in China, 2013-2017
Chart Sales Volume of Eisai China Inc.'s Mecobalamin, 2013-2017
Chart Sales Value of Eisai Co., Ltd.'s Mecobalamin in China, 2013-2017
Chart Sales Volume of Eisai Co., Ltd.'s Mecobalamin in China, 2013-2017
Chart Sales Value of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin, 2013-2017
Chart Sales Value of Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.'s Mecobalamin, 2013-2017
Chart Sales Value of North China Pharmaceutical Company Ltd.'s Mecobalamin, 2013-2017
Chart Prices of Eisai China Inc.'s Mecobalamin (Methycobal) in Parts of China, 2017-2018
Chart Prices of Eisai Co., Ltd.'s Mecobalamin (Methycobal) in Parts of China, 2017-2018
Chart Prices of Jiangsu Sihuan Biopharmaceutical Co., Ltd.'s Mecobalamin (Zhuohe) in Parts of China, 2017-2018
Chart Prices of Nanjing Hailing Pharmaceutical Co., Ltd.'s Mecobalamin (Qixin) in Parts of China, 2017-2018
Chart Prices of North China Pharmaceutical Company Ltd.'s Mecobalamin (Yishenbao) in Parts of China, 2017-2018
Chart Forecast on Sales Value of Mecobalamin in China, 2018-2022

Note: Product cover images may vary from those shown
3 of 4
  • Eisai China Inc.
  • Eisai Co., Ltd.
  • Jiangsu Sihuan Biopharmaceutical Co., Ltd.
  • North China Pharmaceutical Company Ltd.
  • Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
4 of 4

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...

Adroll
adroll